{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:49:45Z","timestamp":1771663785451,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Since the introduction of the aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA), there has been a marked increase in the reported prevalence of this condition among hypertensive, even normotensive, subjects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>But ARR as a spot blood draw for estimating a patient\u2019s aldosterone secretory status is influenced by many factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Here, we describe a series of patients with biochemically confirmed PA, whose diagnosis was delayed by the initial ARR assessment with non-suppressed renin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Patient 1 had a history of resistant hypertension for many years and had a negative initial screening for secondary hypertension (including ARR). At the reevaluation, ARR was close to cutoff still with normal renin after strict and extended drug washout, and the further workup for PA demonstrated a unilateral aldosterone producing adenoma that was surgically removed, with subsequent complete biochemical remission and partial clinical success. Patient 2 was diagnosed with idiopathic hyperaldosteronism combined with obstructive sleep apnea syndrome, which could increase renin resulting in a negative ARR, and finally got a better treatment effect with PA-specific spironolactone, as well as continuous positive airway pressure. Patient 3 with hypokalemia as the main presentation was finally diagnosed with PA after excluding other diseases, and proceeded to laparoscopic adrenalectomy and histologically confirmed an aldosterone producing adenoma. Postoperatively, patient 3 achieved complete biochemical success without any medicine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The clinical status of all three patients was effectively managed, resulting in either complete resolution or notable improvement of their respective conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>After rigorous standardized diagnostic evaluation, there are still many reasons for ARR negative in PA, but they all basically occur in the background of normal or normal-high renin without suppression. A negative screening test result should be repeated and analyzed carefully if this is not consistent with the clinical picture. If, despite a repeatedly negative ARR, clinical suspicion remains high, we recommend consideration of further evaluation, including confirmatory tests and adrenal venous blood sampling (AVS) or even 68Ga-pentixafor PET\/CT to better confirm the diagnosis and improve patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033724","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:05:48Z","timestamp":1684451148000},"page":"e33724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Case series: Primary aldosteronism diagnosed despite normal screening investigations: A report of three cases"],"prefix":"10.1097","volume":"102","author":[{"given":"Minyue","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Lin","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxiao","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Allergy, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice.","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism.","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of The European Society of Hypertension.","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/jc.2010-2603","article-title":"Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone\/renin ratio in normotensive depressed male patients.","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.radcr.2019.04.011","article-title":"Unusual presentation of primary aldosteronism with advanced target organ damage: a case report.","volume":"14","author":"Fava","year":"2019","journal-title":"Radiol Case Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2169\/internalmedicine.54.3267","article-title":"Primary aldosteronism presenting with an atypical aldosterone-renin ratio in the acute phase of cerebral hemorrhage.","volume":"54","author":"Murakami","year":"2015","journal-title":"Intern Med"},{"key":"R9-20250504","first-page":"E188","article-title":"Laparoscopic treatment of primary hyperaldosteronism in a pregnant patient.","volume":"52","author":"Nursal","year":"2009","journal-title":"Can J Surg"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2169\/internalmedicine.2327-18","article-title":"Elevated plasma renin activity caused by accelerated-malignant hypertension in a patient with aldosterone-producing adenoma complicated with renal insufficiency.","volume":"58","author":"Maruhashi","year":"2019","journal-title":"Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.jhh.1000950","article-title":"Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism.","volume":"14","author":"Mansoor","year":"2000","journal-title":"J Hum Hypertens"},{"key":"R12-20250504","first-page":"190","article-title":"Clinical features on diagnosis and treatment of primary aldosteronism combined with obstructive sleep apnea: report of 2 cases and literature review.","volume":"40","author":"Zhe","year":"2019","journal-title":"World Clin Drugs"},{"issue":"8 Suppl B","key":"R13-20250504","first-page":"9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.","volume":"13","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","article-title":"The changing clinical spectrum of primary aldosteronism.","volume":"74","author":"Bravo","year":"1983","journal-title":"Am J Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism.","volume":"2","author":"Catena","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"23247096211034337","DOI":"10.1177\/23247096211034337","article-title":"A real saline challenge: diagnosing primary aldosteronism in the setting of chronic kidney disease.","volume":"9","author":"Mirfakhraee","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40620-022-01267-3","article-title":"Screening for primary aldosteronism is underutilised in patients with chronic kidney disease.","volume":"35","author":"Chauhan","year":"2022","journal-title":"J Nephrol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.","volume":"26","author":"Letavernier","year":"2008","journal-title":"J Hypertens"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma.","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e024632","DOI":"10.1136\/bmjopen-2018-024632","article-title":"Effect of CPAP therapy on kidney function in patients with obstructive sleep apnoea and chronic kidney disease: a protocol for a randomised controlled clinical trial.","volume":"9","author":"Rimke","year":"2019","journal-title":"BMJ Open"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"801689","DOI":"10.3389\/fendo.2021.801689","article-title":"The role of aldosterone in OSA and OSA-related hypertension.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11906-022-01176-7","article-title":"High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it.","author":"Wannachalee","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study.","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study.","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201403-0526OC","article-title":"Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea.","volume":"190","author":"Nicholl","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41371-021-00525-4","article-title":"Aldosterone-producing adenoma associated with non-suppressed renin: a case series.","volume":"36","author":"Jansen","year":"2022","journal-title":"J Hum Hypertens"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"279","DOI":"10.21037\/gs-21-607","article-title":"False-negative aldosterone-to-renin ratio in a primary aldosteronism patient complicated with primary polydipsia: case report.","volume":"11","author":"Zheng","year":"2022","journal-title":"Gland Surg"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"14703203211003780","DOI":"10.1177\/14703203211003780","article-title":"Normotensive presentation in primary aldosteronism: a report of two cases.","volume":"22","author":"Jia","year":"2021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism.","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:03:50Z","timestamp":1746324230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":30,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033724","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}